Archives for September, 2014

Driving as a Functional Endpoint

Driving performance is gaining attention as a danger to consumers of anti-histamine, benzodiazepine, anti-depressant and other medications with residual effects. The FDA and NHTSA (National Highway Transportation Safety Administration) have issued statements about developing mandatory protocols to assess driving-impairment risks of a variety of drugs. How can a sponsor be sure that their drug –…

Read More

Will you be at ISCTM in October? Please let us know so we can arrange time with you.

Will you be at ISCTM in October? Please let us know so we can arrange time with you. How To Reach Us T 866-669-0234 F 208-575-3169 clinicaltrials@btheodore.com

Read More